NDC 79952-110

ZYNLONTA

Loncastuximab Tesirine

ZYNLONTA is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Adc Therapeutics America, Inc.. The primary component is Loncastuximab Tesirine.

• Product ID: 79952-110_12e3f23c-22e0-43bb-ad49-76adc0fefc0f
• NDC: 79952-110
• Product Type: Human Prescription Drug
• Proprietary Name: ZYNLONTA
• Generic Name: Loncastuximab Tesirine
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2021-04-30
• Marketing Category: BLA /
• Application Number: BLA761196
• Labeler Name: ADC Therapeutics America, Inc.
• Substance Name: LONCASTUXIMAB TESIRINE
• Active Ingredient Strength: 10 mg/2mL
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 79952-110-01

1 VIAL, SINGLE-DOSE in 1 CARTON (79952-110-01) > 2 mL in 1 VIAL, SINGLE-DOSE

• Marketing Start Date: 2021-04-30
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details